Answers are grounded in this paper and cite their sources.
HEPATITIS A VACCINE Background Hepatitis A virus (HAV) has traditionally been responsible for mini-epidemics, particularly in areas of poor hygiene and high population density. To decrease the rate of infection, we need to understand the routes of transmission so that targeted, effective vaccination programs can be implemented. Children serve as a source of HAV for adults; specifically, child care center exposure seems to play a role in sporadic as well as in “minor epidemics” of HAV. Because a highly effective vaccine was introduced in 1997, an important research priority is to delineate the impact of this vaccine on the incidence, morbidity, and mortality of HAV infection in children in the postvaccine era and to determine the cost-effectiveness of implementation strategies, such as universal early childhood vaccination. In addition, the vaccine has been recommended for children with liver disease of any type; however, the efficacy of the vaccine in this population has not been investigated. Finally, because HAV may be particularly severe in children with immunodeficiency disorders and may serve as a trigger of autoimmune liver disease in predisposed individuals, an important area for research is to investigate basic mechanisms of viral pathogenesis and the role of host defense. I. Summary of the Problem Rates of Hepatitis A Infection Remain High Both in Developed As Well As in Developing Countries: Standard preventive measures, such as good personal hygiene and immune globulin (IG) administration to exposed persons, have had limited impact on the overall disease burden of hepatitis A. Induction of active immunity against HAV is a possible solution; vaccination offers the long-term benefit of a reduction in the ultimate costs of medical care for chronically infected individuals with liver disease and their contacts. Similarities between the epidemiology of hepatitis A and poliovirus suggest that widespread vaccination of appropriate susceptible population can substantially lower disease incidence, eliminate virus transmission, and ultimately eradicate HAV. Rationale for Prevention of HAV through Active Immunization: Reduction in the incidence of HAV infection will be achieved by producing high levels of immunity in persons in age-groups that have the highest rates of HAV infection and that serve as a reservoir of infection. Producing a highly immune population decreases the incidence of hepatitis A and presumably decreases virus circulation by preventing fecal shredding of HAV. Hepatitis A immunization is likely to substantially lower disease incidence because HAV does not produce a chronic infection, and humans are the only natural reservoir of the virus. Potential (Recommended) Use of Hepatitis A Vaccine: Decisions on how to use hepatitis A vaccine have been based on the epidemiology of the disease; yet many persons with hepatitis A do not identify a risk factor. Major pediatric indications for vaccine are travellers to areas with intermediate to high rates of endemic hepatitis A, children living in defined and circumscribed communities with high endemic rates of periodic outbreaks of HAV infection, and patients with chronic liver disease. Because of their critical role in HAV transmission, children should be a primary focus of immunization strategies to lower disease incidence. The most effective means of achieving control of HAV infection would be to include routing hepatitis A vaccination in the childhood vaccination schedule. The problem, of course, is that there are no data regarding efficacy and cost-effectiveness. II. Major Issues in Need of Investigation • What Is the Epidemiology of HAV (Worldwide) in the Post-vaccine Era? • What Is the Long-term Protection of Hepatitis A Vaccine? Estimates of antibody persistence derived from kinetic models indicate that protective levels of anti-HAV could be present for years. Whether other mechanisms (e.g., cellular memory) also contribute to long-term protection is unknown. “The long-term protective efficacy needs to be determined before recommendations can be made concerning the possible need for booster doses.” • What About Immunization of Infants (e.g., in a universal program)? IG is still recommended for protection from hepatitis A in children younger than 2 years, because residual anti-HAV passively acquired from the mother may interfere with vaccine immunogenicity. Limited data indicate that in seronegative infants, an inactivated HAV vaccine achieves very high seroconversion rates and elicits high antibody concentrations. • What About Routine Childhood Vaccination Against Hepatitis A? AAP and ACIP endorsed vaccination of children living in geographically/ethnically well-defined areas with high rates of HAV infection as well as children in communities where there is an outbreak. Even if this strategy of vaccination is successful, the overall effect will be minimal, because high-risk groups constitute a minority of all those infected. Use of HAV vaccine during community-wide or common-source outbreaks is constrained by logistic difficulties that inevitably lead to delays in implementation. The efficacy of HAV vaccine as postexposure prophylaxis is also under study • What Is the Efficacy of the HAV Vaccine in Children with Liver Disease, Particularly Chronic HCV Infection? III. Proposed Plan to Achieve Goals Determine the Cost-effectiveness and Efficacy of Routine Hepatitis A Immunization “Routine vaccination of children against hepatitis A infection in the 15 states with the highest numbers of infected people could eliminate 75% of all hepatitis A in the U.S.”—Dr. Harold Margolis Several countries and at least 11 states require hepatitis A vaccine for day care or school entry. Universal early-childhood immunization should be implemented immediately, along with catch-up vaccination for school-age children; this would lead to a dramatic reduction in the incidence of HAV infection within a decade. “Failure to begin such a program represents a missed opportunity” (Koff RS: NEJM 340:644–645, 1999). • Develop a Strategy for Developing Countries in Which Hepatitis A Is Hyperendemic Mass immunization of very young children; incorporate hepatitis A vaccine into expanded program of immunization globally. Improvements in water supplies and sanitary standards are the keys to future control of infection Major obstacles include vaccine cost, absence of health-care infrastructure for vaccine delivery, and competing health-care problems • Determine the Cost-effectiveness and Efficacy of Hepatitis A Immunization in Children with Chronic Liver Diseases (such as Chronic HCV, chronic cholestasis, and metabolic liver disease) • Investigate the Unique Basic Mechanisms of Hepatitis A Viral Pathogenesis: The Role of Host Defense in Children This is of particular interest because HAV may be severe in children with immunodeficiency disorders and may serve as a trigger of autoimmune liver disease in predisposed individuals. HEPATITIS B Background Hepatitis B virus (HBV) infection, a public health problem worldwide, is associated with a risk of cirrhosis and hepatocellular carcinoma (HCC). With the implementation of widespread HBV vaccination in many countries, the prevalence of HBV infection and the rate of HCC have been in where a hepatitis B vaccination program was implemented in the incidence of HCC in children has been from children in to in The to immunization against hepatitis B are vaccination of high-risk universal and universal there are to implementation of vaccination Because the of infection is through transmission, would of and immunization of their children; however, implementation is not for universal vaccination of all is the implementation has been by of (e.g., hepatitis would be Vaccination of would protection to the risk of exposure and could be as of a on health those children the problem is a of this is to a of a poor of the of persistence of HBV infection in children infected at and an absence of of and is that the pathogenesis of HBV in the child with immunity is and is the pathogenesis of HBV in the child with immune by immune or administration of in children A priority for HBV research is the of and effective is the only effective for children with chronic hepatitis In most in achieves of and hepatitis B in to of this is well are for rates of viral the long-term impact of this in those children an needs to be effective for chronic HBV in children need to be defined by and for there is a need to identify include and strategies, such as immunization of chronically infected children with should be also be I. Summary of the Problem are obstacles to the implementation of HBV vaccination rates of HBV infection high in This is a particularly for and are high rates of infection in from those countries and in particularly in of Universal vaccination has an of with critical for immune in infected. A of HBV has been in HCC than in the of the The of in the HCC that such may play a role in the of and that may need to be to the of A and effective for children with chronic hepatitis B is most the natural of hepatitis the risk of HCC and with of are in As as are the efficacy of this should be against the risk of in the of the II. Major Issues in Need of Investigation Investigation of means of for universal immunization Investigation of against hepatitis B virus (HBV) infection. the and of HBV may rates and infection with HBV in of and effective for children with HBV infection. Determine the means of the effect of and of such as the of HCC in children with Develop strategies for of HBV infection liver and for III. Proposed Plan to Achieve Goals Develop strategies to vaccine efficacy and Use of to to to against an HBV with health to universal immunization and standards for include for HBV by and of regarding HBV for all to an Hepatitis B to have the to in to a for of data regarding HBV and liver and be by and from in HBV could be HEPATITIS Background Hepatitis virus an was in as the of that there has been an of the of this infection in has been that people are and in the are is HCV infection in children; regarding the epidemiology of this infection in indicate that of infected the infection to their and to a have been a of HCV transmission in children in the The role of use as a risk for of HCV during childhood should be of infection rates during childhood and are are are of with in children; long-term rates from to the rates have been in where the HCV is Because with the of and have rates in pediatric are A of has been to be as effective in as Use of this in children would have the of with levels in of HCV in a preventing the of cirrhosis and liver can have public health I. Summary of the Problem the natural of HCV infection in has been well only a have to this in has been that HCV infection may have a in children than in adults; however, there are a of of liver disease to HCV in young of and HCC in children with chronic HCV have not been the of children with HCV is prevalence rates in the from of children to 11 and of children to of Rates may be in such as the to and medical such as the of children before such as or would be to as would with as in during to with Prevention of HCV infection has been by the of an effective vaccine and of a means of preventing Because the incidence of HCV has the of of for HCV, transmission is the most important means of HCV infection in the pediatric The that of and be to transmission of HCV to the the for the efficacy of and of in in of transmission of area in need of study is that of of the child with of highly effective for HCV is a is no for of children younger than of have been a of of the use of in has been that children may to this than do are are in children to the of and the as well as a of is as to for Children may well to than do adults; however, is likely that the will not be effective and that effective will be before of the infection is an for all is regarding of the child liver The role of HCV in HCC in children is not is to strategy if any should be for early in is a need to public that will the child with HCV from the child with HCV should not be from or The of a child with HCV should in is Children should be of HCV transmission, and the child with HCV needs to be the of The child with HCV should be hepatitis A need to be to and for HCV and to require to the and of a child with are no of the costs of HCV for a child and In the is likely that children need and that would costs of infected children would be of of a child that in viral is likely to be highly because of the high costs of the long-term of chronic liver or Even the of liver for children with HCV are likely to The costs of an child are to are the the possible of chronic liver the of a liver or of are for II. Major Issues in Need of Investigation What is the epidemiology of HCV in The include the of prevalence rates of HCV infection, of the of transmission because use is to be a risk for of HCV in the role of this of transmission of HCV in children and should be so that appropriate can be The prevalence of HCV in medical pediatric and should be can we Because HCV has been from of the of HCV infection is transmission of HCV from the infected mother to the of the and is not because of of and strategies to this of transmission should be The role of to transmission to the should be in with of as should the of in What is the natural of HCV in children and does to the of The rate at liver disease and the risk for of and HCC should be investigated. Whether liver of or other impact on the of liver disease should be What is an effective As are to the of the is that effective can be to the HCV viral can we the of an vaccine for The high of HCV has been vaccine very as has the of models and for Because the of effective has a role in the of a of other viral and is of to of HCV as What are the in the of HCC in are no of because the infection is to be of the of this highly in and because HBV is to be associated with this in seems likely that of HCC in children will is of public health that the prevalence rates of this in children can be the is in infected liver or other would not be if is than is to be at strategies should be can we public to children with HCV and to transmission of The to need to be for III. Proposed Plan to Achieve Goals Develop an effective vaccine by and models of Investigate means of preventing transmission and a to with health to standards for include for HCV by and of regarding HCV for all to an Hepatitis to for HCV prevalence on a as well as in high-risk medical to a could be from as well as with for to a to determine the natural of HCV in children to determine the prevalence of HCC in children to have the to in is defined as of liver with and in an The mortality rate of in is very with by The needs are to understand the of liver those to to for the of most in to to the of in I. Summary of the Problem The of the most by and defined as the of within of in an defined hepatitis as the of that within 2 the of the was to indicate between 2 to a liver to within of the of liver to the of and liver to the of The problem, is to on a of in and in may be and not to What is the from the to the of The of in is a than other in within 2 the of What is the most for and for Is hepatitis a limited to the with of and a that all of the with and that hepatitis and or In addition, is there a between in those in In children with to metabolic or such as infection, or other of the not is the liver Is appropriate that of be in the or and the with and should be in the and metabolic and are the of in children; however, a of Hepatitis virus virus and are in those in countries in HBV infection is hepatitis B virus is the most hepatitis in The infection source or hepatitis B with viral The role of HBV in B is The incidence of hepatitis A in children is lower than that in hepatitis Hepatitis or virus is not an important for in Hepatitis virus can in and young in endemic and such as or or with such as have all been to be the for in to is to the the of the disease in children than may present as with and and other of may lead to and autoimmune hepatitis can also in This for the of of in children; a and and in for the of many patients This is a because may be to or in may be to liver What to be defined is the role of viral in hepatitis of to the data that no could that or is a for in Because the an viral to for other than the are II. Major Issues in Need of Investigation for the of hepatitis and in The such as the and the of the of for liver the liver and with need to be The of the of liver and the pathogenesis of the of the may to the of the the pathogenesis of is the of the between and hepatitis may to delineate the of in for other responsible for to hepatitis in children III. Proposed Plan to Achieve Goals A needs to be to a for in This will be an important for the future and The of hepatitis be of may to the role of and host immune The host cellular and for the of the liver with or or and of the are the to be for may be A good of a is through as the in the of hepatitis virus or hepatitis virus. The other will be to the role of or other in the pathogenesis of in In a for the may the future and the of research a and the mechanisms of may to the and and effective of for this very high mortality disease. Background A of have been to patients with are at the or include with and other with and of has been to be care care with of patients with from to as a of for the of metabolic and have to be or and the of I. Summary of the Problem The of children with be in a pediatric or and with for liver to of the of the liver and of the to and to and liver or can be to the and of liver disease for the of children for and to for to The of is to or the of to or 2 and as a in of or before The of patients with in is or and may trigger not be the is to be is in the of and if the child in a to 2 or or in this does not to overall to be is as a in can be is important to to the of the A. and and an of and Liver liver has been in the in is to be The for is not as good as with other of liver disease. rates between and 75% have been in pediatric The critical of to of and for the of in and no have been for Major Issues in Need of Investigation A. In of the in a high of is for metabolic mechanisms and of the role of in liver the role of in liver of models of severe to in the study of pathogenesis as well as and of The of only do children also than are because of the of the are in need of liver liver III. Proposed Plan to Achieve Goals are recommendations that can be made to of patients with of patients to use of HAV and HBV vaccine on programs to for Background a of autoimmune hepatitis derived from of there a need to understand the pathogenesis of in children and to a of for that can be to the pediatric Mechanisms I. Summary of the Problem The of is a from the into the have that the are to the are also in B and is the role of in disease pathogenesis and on how to The of the to be The as to the is of their or of into the is The that of the those to to the a critical role for because their only is by would in the to present a to the immune In to the pathogenesis are The has been as The to the the of in the the of in the circulation and of patients with 2 has been to be exposed on the liver as a of autoimmune II. Major Issues in Need of Investigation of the of the immune in antibody antibody in of the in of possible and III. Proposed Plan to Achieve Goals A is for the of the of and of defined are and with and other are of are also for the of immune is possible to on immune the and 2 of and the of in the immune the of the and the between and B In of the between and viral is important to investigate the of immunity between virus and I. Summary of the Problem The of on a of defined and by and of globulin or globulin or than the of for with or antibody or liver antibody Hepatitis A, or disease of In pediatric an of is present with liver In those with or there is a of on can between a in children with and in the in those with of on for by at a of or than any of is in because children do not have of children with have of children have and or can be present in chronic hepatitis B and and can be present in chronic hepatitis and in in childhood can be and from and only on Liver antibody is by to be an of autoimmune hepatitis II. Major Issues in Need of Investigation is and in the of The between and on or because is still to to The of to the liver in hepatitis and hepatitis B needs to be III. Proposed Plan to Achieve Goals of by of for of to I. Summary of the Problem the of and the of pathogenesis that to cellular and in predisposed individuals, to in children a to of with in to of II. Major Issues in Need of Investigation all children and with be is there is severe and disease by or The by the Hepatitis in and in The does not groups of effective is achieved by of and and of the with What is the or are the of for children with has been regarding the the or should be as or with have been of and the is to to 2 on the and is associated there is no of the during a of or an in the during to 2 and to 2 The of is to to to and This is because is associated with severe than with The is in those patients with severe associated or not with and in are What is the most means of The to should be by liver at to and is achieved at to during do not the absence of and does not of the disease. The is on and with appropriate the patients do not very The of was by the most patients in only to years. the of does not to is and of the is recommended that should be in those patients with an of or do not to or in with are can at of the and an of the disease. the is with have a of to cirrhosis and than those The most of and are during or no during an What is the with should be by long-term or with of or not with The of cirrhosis does not the to or is not recommended to patients with liver disease. should be The to has not been a is to only liver for at least 2 and there is no or on liver of is only possible in a patients with and in because are very What are have been in of can be as such as or as such as can and in children with with and The is and by of with widespread use of not be in that do not have in the use of this in the of the use of a are of This has as a for chronic liver disease. can and is not reduction of the or of does the What is the for children with Liver should be in children do not to and in those to liver disease or in those with should be liver to of the disease. What is the of children with the The of the of and primary has been there are and have been their are this is to for the because natural as well as the rate of the of the are unknown. III. Proposed Plan to Achieve an for prevalence and to determine the natural on a A could be and could be from as well as from with for Use the to and of A, strategies for chronic hepatitis the of Margolis The prevalence of hepatitis virus infection in the through of Hepatitis A, The of hepatitis A in and in for Hepatitis B A strategy for transmission in the through universal childhood of the Immunization Universal hepatitis B vaccination in and the incidence of hepatocellular carcinoma in Childhood of a derived from a viral hepatitis on Prevention of Hepatitis A for Use of Hepatitis A Vaccine and on of Universal hepatitis B Liver for in the pediatric hepatitis in a liver and in children with Chronic active hepatitis associated with antibody a of of a Hepatitis The for childhood vaccination against hepatitis A. hepatitis associated with in children and A, of hepatitis virus from to The of Hepatitis of children with chronic hepatitis with a A, for chronic hepatitis B in a B associated with hepatitis of in of Is virus
No takes yet. Share an insight, caveat, or question.
Balistreri et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: